The Purpose of the University of Kentucky’s Black Lab

University of Kentucky pic
University of Kentucky
Image: uky.edu

Pharmacist Sherif Mohamed El-Refai is working toward a PhD in pharmaceutical sciences as a student in the doctoral program at the University of Kentucky. Sherif Mohamed El-Refai joined the university’s Black Lab research group to study lung cancer.

Established in 2004, the Black Lab is part of the University of Kentucky’s College of Pharmacy. Maintaining membership with the American Society of Clinical Oncologists, National Lung Cancer Partnership, and American Association for Cancer Research, among other oncology research organizations, the lab and its researchers focus on comprehension of gene expressions and its impact on cancer therapy. This is achieved by designing wet-lab experiments using patient tumors as well as analyzing bio-informatics data.

The lab has successfully produced numerous publications since its inception. In 2015, the group released a publication on how corporate communication strategies can be integrated into doctoral pharmaceutical sciences programs to help students gain communications skills unrelated to science. The previous year, works on endocrine therapy and a phase II study of fulvestrant and everolimus were published. Both concentrated on the breast cancer treatment.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s